Osteoarthritis was previously considered to be solely a disease of cartilage degeneration. However, it is now recognized that all structures in the joint are affected by the disease, notably subchondral bone, in which characteristic changes occur throughout disease progression. These changes in the bone seem to parallel disease progression and are associated with joint pain. This article focuses on the role played by subchondral bone remodeling in the pathogenesis of osteoarthritis and in the expression of pain in this condition. It examines the evidence for altered osteoblast and osteoclast function and the possible involvement of osteocytes in establishing changes in the subchondral bone environment in osteoarthritis. It also explores the biomechanical and genetic influences that may lead to an altered interaction between bone and cartilage. A large number of genes have been found to be differentially expressed in subchondral bone in osteoarthritis compared with osteoporotic or normal bone, and many of these changes persist in osteoblasts derived from osteoarthritic bone. Relevant questions include how the cellular and molecular changes give rise to structural changes in subchondral bone, including bone marrow lesions; what the evidence is that bone marrow lesions are predictive or even causal of disease progression; and whether treatments targeting the subchondral bone could have efficacy in delaying or reversing degeneration of the overlying articular cartilage.